These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 27602961)
1. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells. Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961 [TBL] [Abstract][Full Text] [Related]
2. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells. Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162 [TBL] [Abstract][Full Text] [Related]
4. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma. Cheng Y; Cheng T; Zhao Y; Qu Y Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells. Chandrasekaran KS; Sathyanarayanan A; Karunagaran D Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384 [TBL] [Abstract][Full Text] [Related]
6. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Chandrasekaran KS; Sathyanarayanan A; Karunagaran D Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799 [TBL] [Abstract][Full Text] [Related]
7. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275 [TBL] [Abstract][Full Text] [Related]
8. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells. Sekimoto N; Suzuki A; Suzuki Y; Sugano S Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity. Panneerselvam J; Shanker M; Jin J; Branch CD; Muralidharan R; Zhao YD; Chada S; Munshi A; Ramesh R Oncotarget; 2015 Jun; 6(18):16271-86. PubMed ID: 26009991 [TBL] [Abstract][Full Text] [Related]
10. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer. Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601 [TBL] [Abstract][Full Text] [Related]
11. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617 [TBL] [Abstract][Full Text] [Related]
13. MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1. Chen CY; Chang JT; Ho YF; Shyu AB Nucleic Acids Res; 2016 May; 44(8):3772-87. PubMed ID: 27025651 [TBL] [Abstract][Full Text] [Related]
14. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
15. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1. Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022 [TBL] [Abstract][Full Text] [Related]
16. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion. Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Fang Y; Xue JL; Shen Q; Chen J; Tian L Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835 [TBL] [Abstract][Full Text] [Related]
18. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG. Wang P; Deng Y; Fu X Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843 [TBL] [Abstract][Full Text] [Related]